1. Home
  2. SOBR vs XBIO Comparison

SOBR vs XBIO Comparison

Compare SOBR & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOBR
  • XBIO
  • Stock Information
  • Founded
  • SOBR 2004
  • XBIO N/A
  • Country
  • SOBR United States
  • XBIO United States
  • Employees
  • SOBR N/A
  • XBIO N/A
  • Industry
  • SOBR Newspapers/Magazines
  • XBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SOBR Consumer Discretionary
  • XBIO Health Care
  • Exchange
  • SOBR Nasdaq
  • XBIO Nasdaq
  • Market Cap
  • SOBR 5.2M
  • XBIO 4.4M
  • IPO Year
  • SOBR N/A
  • XBIO N/A
  • Fundamental
  • Price
  • SOBR $3.42
  • XBIO $3.42
  • Analyst Decision
  • SOBR
  • XBIO Hold
  • Analyst Count
  • SOBR 0
  • XBIO 1
  • Target Price
  • SOBR N/A
  • XBIO N/A
  • AVG Volume (30 Days)
  • SOBR 86.8K
  • XBIO 2.6M
  • Earning Date
  • SOBR 11-13-2025
  • XBIO 11-10-2025
  • Dividend Yield
  • SOBR N/A
  • XBIO N/A
  • EPS Growth
  • SOBR N/A
  • XBIO N/A
  • EPS
  • SOBR N/A
  • XBIO N/A
  • Revenue
  • SOBR $301,400.00
  • XBIO $2,446,221.00
  • Revenue This Year
  • SOBR N/A
  • XBIO $1.99
  • Revenue Next Year
  • SOBR N/A
  • XBIO $20.00
  • P/E Ratio
  • SOBR N/A
  • XBIO N/A
  • Revenue Growth
  • SOBR 73.21
  • XBIO N/A
  • 52 Week Low
  • SOBR $2.41
  • XBIO $2.20
  • 52 Week High
  • SOBR $69.39
  • XBIO $13.93
  • Technical
  • Relative Strength Index (RSI)
  • SOBR 49.57
  • XBIO 43.80
  • Support Level
  • SOBR $3.10
  • XBIO $3.56
  • Resistance Level
  • SOBR $3.47
  • XBIO $4.15
  • Average True Range (ATR)
  • SOBR 0.30
  • XBIO 0.68
  • MACD
  • SOBR 0.00
  • XBIO -0.24
  • Stochastic Oscillator
  • SOBR 45.71
  • XBIO 2.15

About SOBR SOBR Safe Inc.

Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: